Sept. 22 (UPI) -- The Food and Drug Administration on Wednesday approved a third booster dose for the Pfizer-BioNTech COVID-19 vaccine.
The FDA issued the emergency clearance allowing booster shots for people older than 65 as well as people aged 18-64 who are at high risk of severe COVID-19 and who face frequent institutional or occupational exposure to COVID-19.